Global Top 25 Companies in the Animal Health Market 2026: Company Profile by Transpire Insight

By Transpire Insight

---

Description

According to a research report published by Transpire Insight, the global animal health market size is projected to grow from USD 64.00 billion in 2026 to USD 100.50 billion by 2035, at a CAGR of 8.05 % during the forecast period 2026-2035. The market grows due to the rising trend of pet humanization, the growing middle class eating more meat, the increased threat from zoonotic emerging diseases, and the fast pace of integration of point-of-care veterinary diagnostics.

Introduction 

The animal health market is a global one, covering the development, production, and commercialization of animal health pharmaceuticals, animal health vaccines, animal health diagnostics, and animal health medicated feed additives. It is very important for the health and productivity of humans, domestic animals, and pets. The prominent role played by food security and emotional human-animal relationships is driving a rapid shift in the industry to a preventative approach and precision digital monitoring. In a world where zoonotic threats are constantly changing, this multi-billion-dollar industry plays a crucial role in safeguarding global public health, food security, and advancing veterinary care practices and understanding worldwide.

Recent Development News

March 2026: The American Veterinary Medical Association (AVMA) published major regulatory updates to streamline FDA animal drug development pathways, significantly accelerating how novel, targeted biopharmaceuticals and precision digital health therapies clear approval gates for clinical deployment.

June 2026: Merck Animal Health received widespread regulatory momentum following the full integration of its newly acquired aquaculture assets, commercializing next-generation DNA-based fish vaccines and smart tracking and monitoring technologies across primary global marine farming markets.

Stay Ahead of Emerging Opportunities with Expert Market Insights by Transpire Insight

Transpire Insight provides comprehensive, data-driven market intelligence to support smarter business decisions. Our research is rooted in comprehensive analysis, authoritative predictions, and industry expertise, enabling organizations to make informed decisions in rapidly evolving markets. In-depth analysis of market segmentation, competitive positioning, regional trends, and emerging investment opportunities in high-growth areas. We blend accuracy with actionable intelligence, empowering companies to uncover new avenues for growth, bolster strategic decision-making, and stay ahead in a dynamic global market. 

Download the exclusive Animal Health Market sample report today to uncover expert insights, emerging trends, and the opportunities defining the future of the industry.

Animal Health Market Size & Statistics

• The market size for animal health is estimated to be worth USD 64.00 billion in 2026.

• The market size is going to expand at a CAGR of 8.05% between 2026 and 2035.

• The global animal health market Size is anticipated to reach USD 100.50 billion by 2035.

• North America is estimated to generate the highest demand during the forecast period, with a growth of 41% in the Animal Health market.

• Asia-Pacific is projected to grow the fastest during the forecast period at a growth rate of 14% in the Animal Health market.

Regional Growth and Demand Analysis by Transpire Insight: North America is expected to generate the highest demand during the forecast period in the Animal Health market, capturing a dominant revenue share of approximately 35%. The dominant player in the Animal Health Market is North America, owing to the availability of leading players in terms of veterinary pharmaceutical companies, advanced research laboratories, and robust consumer investment in companion animal medical insurance. The United States is currently the biggest producer in the Animal Health Market, considering factors such as the presence of extensive veterinary diagnostic manufacturing operations, national efforts toward managing zoonotic disease outbreaks, and continued advancement in biotechnology engineering. As of 2025, some of the animal health companies in the United States have undertaken production activities aimed at manufacturing superior biologicals and monoclonal antibodies that would enhance next-generation livestock security and companion animal long-term care.

Asia Pacific is anticipated to grow the fastest during the forecast period in the Animal Health market, projected to expand at a double-digit growth rate. It is expected that the Asia-Pacific region will witness the highest growth rate during the forecast period due to increasing demand for commercial animal protein, growing populations of companion pets, increased livestock purchasing programs, and significant investment in agricultural disease control infrastructure. China, India, Japan, and South Korea are some of the rapidly growing nations regarding livestock husbandry and urban pet ownership activities that drive the demand for advanced veterinary preventative technologies. In 2026, there will be an increase in herd modernization and biosecurity programs by many animal health agencies and commercial farming groups in China and India. This was done with the aim of ensuring energy-efficient diagnostic testing and antibiotic-free medicated feed systems.

Top 15 Trends in the Animal Health Market 

• Pet humanization is driving premium companion animal care.

• AI adoption across diagnostics, imaging, and herd management.

• Rise of biologics and monoclonal antibody therapies.

• Growth in JAK inhibitors and dermatology treatments.

• Expansion of preventive and wellness-focused pet products.

• Increasing M&A and industry consolidation activity.

• Zoonotic disease concerns fuel vaccine investment.

• Telemedicine and remote veterinary consultation growth.

• Precision livestock health and genomics adoption.

• Needle-free and long-acting drug formulations.

• Regulatory evolution and earlier developer-agency engagement.

• Rising veterinary costs and pricing pressures,

• Online/e-commerce veterinary pharmacy expansion.

• Asia-Pacific is emerging as the fastest-growing region.

• Rising pet insurance uptake and adoption.

Proceed to Checkout to purchase the exclusive Animal Health Market report and gain instant access to in-depth market intelligence, strategic analysis, and future growth opportunities.

• AI in Diagnostics & Imaging

Veterinary providers are adopting AI-enabled imaging tools that assist in detecting abnormalities during surgical and radiology procedures, improving precision and outcomes across companion animal care.

• Pet Humanization

Pets are increasingly regarded as family members rather than solely as animals, driving greater investment in companion animal health and well-being globally.

• Biologics & Precision Genomics

Zoetis announced the acquisition of Neogen's Animal Genomics business, strengthening precision livestock breeding and predictive animal health analytics capabilities in March 2026.

• Industry Consolidation

Covetrus and MWI Animal Health agreed to an all-share-plus-cash merger valued at about USD 3.5 billion, combining tech and distribution strengths.

• Regulatory-Development Alignment

Development timelines are often extended not due to a lack of innovation, but because regulatory engagement happens too late, prompting earlier collaboration between developers and regulators.

• Telemedicine Expansion

Key trends include rising use of biologics and monoclonal antibodies, growth in precision veterinary care, expansion of needle-free treatments, digital livestock innovations, and increasing telemedicine adoption.

Top 25 Companies Leading the Animal Health Market 

• Zoetis

• Elanco Animal Health

• Boehringer Ingelheim Animal Health

• Merck Animal Health

• Bayer Animal Health

• Ceva Santé Animale

• Virbac

• Vetoquinol

• IDEXX Laboratories

• Phibro Animal Health Corporation

• Dechra Pharmaceuticals

• Neogen Corporation

• Norbrook Laboratories

• HIPRA,

• Kyoritsu Seiyaku

• Huvepharma

• Zydus Animal Health

• Covetrus

• Heska Corporation

• Mars Petcare

• VCA Inc.

• Bimeda Animal Health

• Indian Immunologicals Limited

• Allflex Livestock Intelligence

• Patterson Companies

Customize the exclusive Animal Health Market report today to receive tailored insights, country-specific analysis, and business-focused market intelligence.

Leading Animal Health Market to Watch Globally

Top 25 Companies Leading the Animal Health Market

1. Zoetis

Remains the largest standalone veterinary medicine and vaccine corporation globally.

Founded: 1952 | HQ: Parsippany, New Jersey, USA.

Why It Ranks: Commands top revenues via breakthrough companion animal dermatology treatments.

Regional Dominance: Holds unrivaled commercial leadership and market share across North America.
IMARC Group

Product Line: Next-generation parasiticides, vaccines, monoclonal antibodies, and diagnostic instruments.

2. Elanco Animal Health

Fully transitioned into an independent public entity from Eli Lilly.

Founded: 1954 | HQ: Greenfield, Indiana, USA.

Why It Ranks: Positioned heavily in livestock sustainability initiatives and consumer pet care.

Regional Dominance: Maintains deeply entrenched market networks throughout American and European territories.

Product Line: Medicated feed additives, parasiticides, treatments, and disease preventatives.

3. Boehringer Ingelheim Animal Health

Operates successfully as the premier family-owned veterinary biological enterprise.

Founded: 1885 | HQ: Ingelheim, Germany.

Why It Ranks: Globally renowned for producing market-leading flea and tick preventative brands.

Regional Dominance: Anchors immense commercial authority across primary livestock markets in Europe.

Product Line: Specialized pet antiparasitics, swine vaccines, and equine health therapeutics.

4. Merck Animal Health

Operates commercially under the operational name MSD Animal Health internationally.

Founded: 1891 | HQ: Rahway, New Jersey, USA.

Why It Ranks: Successfully merges advanced pharmaceutical chemistry with tech-driven livestock identification tracking.

Regional Dominance: Exerts profound supply chain control across North America and Europe.

Product Line: Innovative veterinary vaccines, diabetes management solutions, and aquatic monitoring software.

5. Elanco Animal Health

Completed a full corporate separation from pharmaceutical titan Eli Lilly in 2018.

Founded: 1954| HQ: Greenfield, Indiana, USA.

Why It Ranks: Commands top global market shares in pet parasiticides and production animal sustainability.

Regional Dominance: Maintains deeply entrenched veterinary and agricultural distribution networks throughout American and European territories.

Product Line: Medicated feed additives, parasiticides, treatments, and livestock disease preventatives.

6. Ceva Santé Animale

Recognized widely as an aggressive, fast-growing global veterinary biological manufacturer.

Founded: 1999 | HQ: Libourne, France.

Why It Ranks: Leads crucial innovation fields for industrial poultry and swine reproduction.

Regional Dominance: Controls substantial commercial market territory across Europe and Latin America.

Product Line: Mass-poultry cardiology treatments, multi-strain vaccines, and behavioral companion pheromones.

7. Virbac

Dedicated exclusively to veterinary health products since its initial founding.

Founded: 1968 | HQ: Carros, France.

Why It Ranks: Delivers highly practical, comprehensive therapeutic catalogs for independent veterinary clinics.

Regional Dominance: Sustains stable, long-term brand presence across pan-European medical practices.

Product Line: Clinical pet dental items, dermatology therapies, vaccines, and specialized antibiotics.

8. Vetoquinol

A multi-generational family business exporting solutions to over one hundred nations.

Founded: 1933 | HQ: Lure, France.

Why It Ranks: Focuses intensely on profitable niches like veterinary pain management therapies.

Regional Dominance: Possesses deep, historical customer integration within mature Western European economies.

Product Line: Target anti-inflammatories, anti-infectives, joint mobility supplements, and cardiovascular drugs.

9. IDEXX Laboratories

Fact: Specializes purely in diagnostic technological breakthroughs rather than conventional pharmaceuticals.

Founded: 1983 | HQ: Westbrook, Maine, USA.

Why It Ranks: Undisputed world leader in clinical point-of-care instruments and laboratory networks.

Regional Dominance: Controls the vast majority of veterinary diagnostic workflows in North America.

Product Line: Chemistry analyzers, point-of-care rapid tests, reference laboratory services, and software.

10. Phibro Animal Health Corporation

Expanded from a basic chemical distribution business into global animal agriculture.

Founded: 1946 | HQ: Teaneck, New Jersey, USA.

Why It Ranks: Essential provider of foundational nutrition solutions optimizing global food-animal production.

Regional Dominance: Retains heavy commercial volume placement throughout major livestock exporting countries.

Product Line: Mineral feed ingredients, vaccine technologies, anti-infectives, and sanitation processing aids.

Schedule a meeting with our market experts to discuss the exclusive Animal Health Market report and identify the best research solution for your organization.

Conclusion

The animal health market is in a very transformative period, shifting from 'reactive' treatment to 'predictive' and 'preventative' treatment. In the context of both premiumization in the companion animal market and agricultural productivity demands, market leaders are increasingly turning to cutting-edge biotechnology and digital diagnostic ecosystems. The competitive environment highlights the need for a unified approach to livestock biosecurity and companion animal longevity. In the end, the future of the industry over the coming decade will be driven by continued investment in next-generation biologicals as well as data-driven veterinary care.